Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide

Cancer Letters

Volumn 271, Issue 1, 2008, Pages 47-55

  Lee, Hyun Soo ^a   Park, Chan Bae ^a   Kim, Jung Min ^a   Jang, Su A ^a   Park, In Yup ^a   Kim, Mi Sun ^b   Cho, Ju Hyun ^c   Kim, Sun Chang ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Korea Institute of Energy Research (KIER)   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Anticancer peptide; Buforin IIb; Ganglioside; Histone H2A

Indexed keywords

BUFORIN IIB; GANGLIOSIDE; HISTONE H2A; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL KILLING; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; PROTEINS;

MUS;

EID: 53049110294     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.041     Document Type: Article

References (16)

1. ez-Tomás R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem. 13 (2006) 1859-1876
2. Papo N., and Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol. Life Sci. 62 (2005) 784-790
3. Sharma S.V. Melittin resistance: a counterselection for ras transformation. Oncogene 7 (1992) 193-201
4. Moore A.J., Devine D.A., and Bibby M.C. Preliminary experimental anticancer activity of cecropins. Pept. Res. 7 (1994) 265-269
5. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., and Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl. Acad. Sci. USA 88 (1991) 3792-3796
6. Yi G.S., Park C.B., Kim S.C., and Cheong C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett. 398 (1996) 87-90
7. Park C.B., Kim H.S., and Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244 (1998) 253-257
8. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., and Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 97 (2000) 8245-8250
9. Dallaporta B., Hirsch T., Susin S.A., Zamzami N., Larochette N., Brenner C., Marzo I., and Kroemer G. Potassium leakage during the apoptotic degradation phase. J. Immunol. 160 (1998) 5605-5615
10. Hancock R.E., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006) 1551-1557
11. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11 (1993) 105-128
12. Hanai N., Nakamura K., and Shitara K. Recombinant antibodies against ganglioside expressed on tumor cells. Cancer Chemother. Pharmacol. 46 (2000) S13-S17
13. Bitton R.J., Guthmann M.D., Gabri M.R., Carnero A.J., Alonso D.F., Fainboim L., and Gomez D.E. Cancer vaccines: an update with special focus on ganglioside antigens. Oncol. Rep. 9 (2002) 267-276
14. Papo N., Seger D., Makovitzki A., Kalchenko V., Eshhar Z., Degani H., and Shai Y. Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res. 66 (2006) 5371-5378
15. Chen Y., Xu X., Hong S., Chen J., Liu N., Underhill C.B., Creswell K., and Zhang L. RGD-Tachyplesin inhibits tumor growth. Cancer Res. 61 (2001) 2434-2438
16. Mai J.C., Mi Z., Kim S.H., Ng B., and Robbins P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 61 (2001) 7709-7712